Cutera Inc. (CUTR, Financial) experienced a significant stock price decline of 5.14%, bringing its price to $0.751 per share. The trading volume reached 26,733 shares, with a turnover rate of 0.13% and a price fluctuation of 5.03%.
According to the latest financial report, Cutera reported revenue of $34.38 million and a net loss of $24.68 million, resulting in an earnings per share (EPS) of -$1.23. The gross profit for the period was $6.27 million, with a price-to-earnings (P/E) ratio of -0.10.
Analyst ratings reveal mixed sentiments: 25% of the four rating agencies recommend buying the stock, while 75% advise holding it. No agencies have suggested selling the stock.
The medical device industry, where Cutera operates, saw an overall decline of 0.27%. In this sector, significant gainers included Ainos Inc C/Wts 29/07/2027 (To Pur Com) and Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 (To Pur Com), while Tenon Medical, Inc. and Bone Biologics Corp showed high trading activity with turnover rates of 63.35% and 22.05%, respectively. Ainos Inc C/Wts 29/07/2027 (To Pur Com) and Beyond Air, Inc. experienced notable price fluctuations of 80.40% and 27.59%, respectively.
Cutera Inc. specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetic systems. Their products include the Enlighten, Excel HR, Excel V, Xeo, and Trusculpt 3D, marketed under various trademarks. The company's offerings enable medical practitioners to perform safe procedures such as acne treatment, body contouring, skin resurfacing, hair removal, tattoo removal, and treatment of benign pigmented and vascular lesions. Most of Cutera's revenue is derived from its U.S. operations.
